Based on the analysis of the percentage of elevated concentrations, we indicated that the combined analysis of CXCL1 and CXCR1 with the classical tumor marker might be more useful in the diagnosis of CRC in comparison to the measurement of a single biomarker. This evidence concerns the gene CXCL1 and colorectal carcinoma.